ARK Genomic Revolution ETF
ARKG
286 hedge funds and large institutions have $433M invested in ARK Genomic Revolution ETF in 2023 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 64 increasing their positions, 88 reducing their positions, and 42 closing their positions.
7% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 42
8% less call options, than puts
Call options by funds: $36.9M | Put options by funds: $40.3M
1% less funds holding
Funds holding: 290 → 286 (-4)
5.85% less ownership
Funds ownership: 30.96% → 25.11% (-5.8%)
27% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 88
35% less capital invested
Capital invested by funds: $666M → $433M (-$233M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMEA
Main Management ETF Advisors
San Francisco,
California
|
+$7.27M |
| 2 |
CCM
Cinctive Capital Management
New York
|
+$6.54M |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$4.46M |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$2.36M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$48.3M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$37.8M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$27M |
| 4 |
Citigroup
New York
|
-$25.2M |
| 5 |
Morgan Stanley
New York
|
-$5.54M |
ARKG Hedge Fund Activity: Q3 2023 in Review
286 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q3 2023, worth a combined $433M — down 35% from $666M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of ARKG and 39 opened new positions — a net loss of 3 holders — while 88 trimmed existing stakes and 64 added.
The largest buyer was Main Management ETF Advisors, adding an estimated $7.27M. The largest seller was Wells Fargo, cutting an estimated $48.3M.
- 286 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q3 2023, down from 290 in Q2 2023.
- Funds reported $433M of ARK Genomic Revolution ETF stock for Q3 2023, down 35% quarter-over-quarter.
- 39 funds opened new ARK Genomic Revolution ETF positions in Q3 2023 and 42 closed out, a net change of -3 holders.
- The largest ARK Genomic Revolution ETF buyer in Q3 2023 was Main Management ETF Advisors, an estimated $7.27M added.
- The largest ARK Genomic Revolution ETF seller in Q3 2023 was Wells Fargo, an estimated $48.3M sold.
Based on aggregated 13F filings for Q3 2023.